bioRxivNeurosciencePreprint
Global ribosome profiling reveals that mutant huntingtin stalls ribosomes and represses protein synthesis independent of fragile X mental retardation protein
Mehdi EshraghiiD, Pabalu P. KarunadharmaiD, Juliana BliniD, Neelam ShahaniiD, Emiliano P. RicciiD, Audrey M. MicheliD, Nicolai T. UrbaniD, Nicole GalliiD, Sumitha Rajendra Rao, Manish SharmaiD, Katie Florescu, Srinivasa SubramaniamiD
Abstract
The regulators that stall ribosome translocation are poorly understood. We find that polyglutamine-expanded mutant Huntingtin (mHtt), the Huntingtons disease (HD) causing protein, promotes ribosome stalling and physiologically suppresses protein synthesis. A comprehensive, genome-wide analysis of ribosome footprint profiling (Ribo-Seq) revealed widespread ribosome stalling on mRNA transcripts and a shift in the distribution of ribosomes toward the 5 end, with single-codon unique pauses on selected mRNAs in HD cells. In Ribo-Seq, we found fragile X mental retardation protein (FMRP), a known regulator of ribosome stalling, translationally upregulated and it co-immunoprecipitated with mHtt in HD cells and postmortem brain. Depletion of FMRP gene, Fmr1, however, did not affect the mHtt-mediated suppression of protein synthesis or ribosome stalling in HD cells. Consistent with this, heterozygous deletion of Fmr1 in Q175FDN-Het mouse model, Q175FDN-Het; Fmr1+/-, showed no discernable phenotype, but a subtle deficit in motor skill learning. On the other hand, depletion of mHtt, which binds directly to ribosomes in an RNase-sensitive manner, enhanced global protein synthesis, increased ribosome translocation and decreased stalling. This mechanistic knowledge advances our understanding of the inhibitory role of mHtt in ribosome translocation and may lead to novel target(s) identification and therapeutic approaches that modulate ribosome stalling in HD.\n\nOne Sentence SummaryHuntingtons disease (HD) protein, mHtt, binds to ribosomes and affects their translocation and promotes stalling independent of the fragile X mental retardation protein.
- organism: human
- organism: mouse
- assay: Ribo-seq
- research focus: differential expression
- research focus: protein structure prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 9
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ribosome Profiling Reveals a Dichotomy Between Ribosome Occupancy of Nuclear-Encoded and Mitochondrial-Encoded OXPHOS mRNA Transcripts in a Striatal Cell Model of Huntington Disease
Srinivasa Subramaniam, Neelam Shahani·bioRxiv·Jan 30, 2021
- The Human Fragile X Mental Retardation Protein Inhibits the Elongation Step of Translation through its RGG and C-terminal domains
Y. M. Athar, S. Joseph·bioRxiv·Jun 25, 2020
- Progressive alterations in polysomal architecture and activation of ribosome stalling relief factors in a mouse model of Huntington's disease
Eva Martin‐Solana, Irene Díaz‐López, … Marı́a Rosario Fernández-Fernández·Neurobiology of DiseasePeer-reviewed·Mar 31, 2024
- A role of cellular translation regulation associated with toxic Huntingtin protein
H. Joag, V. Ghatpande, … A. Majumdar·bioRxiv·Jul 1, 2019
- Nascent mutant Huntingtin exon 1 chains do not stall on ribosomes during translation but aggregates do recruit machinery involved in ribosome quality control
A. R. Ormsby, D. Cox, … D. M. Hatters·bioRxiv·May 13, 2020
- Ribotoxic collisions on CAG expansions disrupt proteostasis and stress responses in Huntington's Disease
Ranen Aviner, Ting-Ting Lee, … Judith Frydman·bioRxiv·May 4, 2022